Premium
Oral contraceptive therapy reduces serum relaxin‐2 in elite female athletes
Author(s) -
NoseOgura Sayaka,
Yoshino Osamu,
YamadaNomoto Kaori,
Nakamura Mariko,
Harada Miyuki,
Dohi Michiko,
Okuwaki Toru,
Osuga Yutaka,
Kawahara Takashi,
Saito Shigeru
Publication year - 2017
Publication title -
journal of obstetrics and gynaecology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 50
eISSN - 1447-0756
pISSN - 1341-8076
DOI - 10.1111/jog.13226
Subject(s) - relaxin , luteal phase , medicine , follicular phase , endocrinology , dienogest , athletes , hormone , luteinizing hormone , endometriosis , physical therapy
Aim Recent investigations have demonstrated that athletes with high relaxin‐2 levels have a high risk of anterior cruciate ligament injuries, while athletes taking oral contraceptives (OC) have low relaxin‐2 levels. It has not yet been clarified whether taking OC reduces relaxin‐2 levels. The purpose of this study was to investigate changes in relaxin‐2 levels in athletes taking OC. Methods Levels of relaxin‐2, estradiol, progesterone, luteinizing hormone and follicle‐stimulating hormone were measured in serum samples ( n = 183) from 106 elite female athletes. Five athletes with serum relaxin‐2 concentrations > 6 pg/mL during the luteal phase were recruited to assess the effect of OC therapy. Results Serum relaxin‐2 concentrations were significantly higher during the luteal phase ( n = 57) than in the follicular phase ( n = 72), or in athletes on OC therapy ( n = 10) ( P < 0.001, P < 0.001 and P < 0.05, respectively). In the luteal phase, 36.8% (21/57) of the athletes had relaxin levels > 6 pg/mL. In 23 athletes, serum relaxin‐2 concentrations were measured during both the follicular and luteal phases, revealing that relaxin‐2 levels were significantly higher in the luteal phase compared with the follicular phase. In 5 out of 23 athletes, serum relaxin‐2 concentrations were > 6 pg/mL in the luteal phase and during the second cycle of OC therapy, relaxin‐2 concentrations decreased dramatically to below the detection limit (0.26 pg/mL). Conclusions High serum relaxin‐2 concentrations were only detected during the luteal phase. In athletes with high relaxin‐2 concentrations during the luteal phase, OC therapy decreased serum relaxin‐2 levels.